Precigen (PGEN) Change in Accured Expenses (2012 - 2026)
Precigen (PGEN) reported Change in Accured Expenses of -$2.3 million for Q1 2026, down 277.92% year-over-year from $1.3 million in Q1 2025, and down 4469.23% quarter-over-quarter from $52000.0 in Q4 2025.
Precigen (PGEN) Change in Accured Expenses (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Change in Accured Expenses data on file, last reported at -$2.3 million in Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at -$2.3 million, down 277.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 million (up 834.2% YoY), and the FY2025 annual result was $6.7 million, up 464.64% from the prior year.
- Change in Accured Expenses slipped to -$2.3 million in Q1 2026 per PGEN's latest filing, from $52000.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $4.1 million in Q2 2025 and troughed at -$3.2 million in Q4 2024.
- A 5-year average of $456058.8 and a median of $52000.0 in 2025 frame the typical range for Change in Accured Expenses.
- On a YoY basis, Change in Accured Expenses climbed as much as 9926.67% in 2022 and fell as far as 3390.91% in 2022.
- A 5-year view of Change in Accured Expenses shows it stood at $41000.0 in 2022, then jumped by 3819.51% to $1.6 million in 2023, then plunged by 296.95% to -$3.2 million in 2024, then jumped by 101.64% to $52000.0 in 2025, then tumbled by 4469.23% to -$2.3 million in 2026.
- Business Quant data shows PGEN's Change in Accured Expenses at -$2.3 million in Q1 2026, $52000.0 in Q4 2025, and $1.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 931,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | -2.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.27 Mn |
| Mar 31, 2026 | -2.27 Mn |
| Dec 31, 2025 | 52,000.00 |
| Dec 31, 2025 | 52,000.00 |
| Sep 30, 2025 | 1.23 Mn |
| Sep 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 4.10 Mn |
| Jun 30, 2025 | 4.10 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | -3.17 Mn |
| Dec 31, 2024 | -3.17 Mn |
| Sep 30, 2024 | -130,000.00 |
| Sep 30, 2024 | -130,000.00 |
| Jun 30, 2024 | 1.59 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Mar 31, 2024 | -126,000.00 |
| Mar 31, 2024 | -126,000.00 |
| Dec 31, 2023 | 1.61 Mn |
| Dec 31, 2023 | 1.61 Mn |